We heard the other day from attorneys involved in the MDL direct filing, choice-of-law case that we wrote about a couple of weeks ago, Looper v. Cook Inc. Engaging in this kind of dialogue is one of the joys of blogging, even when our friends and colleagues write to tell us we got
Choice Of Law
This Is Why You Should Think Twice About MDL Direct Filing

We have long thought that “direct filing” procedures in multidistrict litigation were a solution in search of a problem. We also think direct filing procedures in MDLs pose significant waiver risks without a corresponding upside. Alas, our inclinations were confirmed recently when the Seventh Circuit ruled that a mass tort defendant’s acquiescence to complaints filed…
Eighth Circuit Upholds Application of Ohio Law to Dismiss Bair Hugger Case

“Location, location, location” isn’t a mantra only for real estate agents. Location also matters to lawyers. In Axline v. 3M Co., 2021 WL 3411822 (8th Cir. Aug. 5, 2021), whether the Bair Hugger product liability case could go forward turned on the choice of law between Minnesota and Ohio. The Eighth Circuit affirmed the…
E.D. Virginia Reins in Horse Drug Class Action

In Knapp v. Zoetis Inc., 2021 U.S. Dist. Lexis 63783 (E.D. Va. March 31, 2021), the plaintiff alleged that administration of an equine antibiotic caused his horse, Boomer, to experience “persistent lameness” and permanent damage to the “musculature in his neck.” Boomer was not okay. His condition was far from stable.
The plaintiff claimed…
Court Chooses New Hampshire Product Liability Law: Not-so-Granite Principles

This post is from the Reed Smith side of the blog only.
Yesterday was National Punctuation Day; it is a good time to administer a semi-colonic to turgid prose. Today we apply an exclamation mark to our unhappiness with judges whose choice of law principles seem not so, er, principled.
Last Thursday, Bexis commented on…
Unsound, Ongoing MDL Choice of Law Fiasco

This post is solely the product of the Reed Smith side of the Blog.
Readers may recall that a couple years ago we proposed reworking the federal multi-district litigation statute, 28 U.S.C.A. §1407, in a variety of ways. Simultaneously, some of us have been working with Lawyers for Civil Justice to attempt MDL change through…
Accutane Litigation Goes Out with a Bang, Not a Whimper

It’s been a long road. Well after product liability litigation over Accutane and inflammatory bowel disease (“IBD”) had been thoroughly debunked everywhere else in the nation, such litigation lived on in New Jersey – for year after interminable year. First, a number of trials occurred, but literally every verdict for the plaintiffs was reversed on…
Florida Court Says No to Preemption and No to Punitive Damages

It can sometimes be difficult for us here at the DDL Blog to address “mixed bag” cases. We are quite clear that we are a defense side blog. Love us or hate us – we don’t pull punches. We hoard and covet preemption and learned intermediary wins and treat each one like the gem that…
Some Ideas About Innovator Liability

Once again we find ourselves in the position of creating new defenses to a novel, plaintiff-side cause of action. This time, we’ve been doing a lot of thinking about innovator liability – the theory that would hold branded manufacturers liable for injuries allegedly caused by the ingestion of (preemption-immune) generic drugs on some kind of…
Pennsylvania Risperdal Decision Doesn’t Go As Far As Plaintiffs Suggest

This post is from the non-Dechert side of the blog.
While the recent Pennsylvania Superior Court Risperdal decision is not a defense victory, it is certainly not as favorable for plaintiffs as they are making it out to be. While several issues were presented for appeal in Stange v. Janssen Pharms., Inc., 2018 Pa.…